Drug Report History
Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.
The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.
| Version v6-FR | Version v1-EN | |
|---|---|---|
| Language | French | English |
| Date Updated | 2022-08-25 | 2022-04-12 |
| Drug Identification Number | 00717002 | 00717002 |
| Brand name | VIADERM KC CRM | VIADERM KC CRM |
| Common or Proper name | VIADERM KC | VIADERM KC |
| Company Name | TARO PHARMACEUTICALS INC | TARO PHARMACEUTICALS INC |
| Ingredients | NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE | NYSTATIN GRAMICIDIN NEOMYCIN TRIAMCINOLONE ACETONIDE |
| Strength(s) | 100000UNIT 0.25MG 2.5MG 1MG | 100000UNIT 0.25MG 2.5MG 1MG |
| Dosage form(s) | CREAM | CREAM |
| Route of administration | TOPICAL TOPICAL | TOPICAL TOPICAL |
| Packaging size | 15 | 15 |
| ATC code | D07CB | D07CB |
| ATC description | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS | CORTICOSTEROIDS, COMB WITH ANTIBIOTICS |
| Reason for shortage | Disruption of the manufacture of the drug. | Disruption of the manufacture of the drug. |
| Anticipated start date | ||
| Actual start date | 2022-08-02 | 2022-04-08 |
| Estimated end date | 2022-09-09 | 2022-04-22 |
| Actual end date | ||
| Shortage status | Actual shortage | Actual shortage |
| Tier 3 Status | No | No |
| Company comments | ||
| Health Canada comments |